Balyasny Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,106
| Closed | -$124K | – | 2518 |
|
|
2024
Q1 | $124K | Buy |
+23,106
| New | +$124K | ﹤0.01% | 1860 |
|
|
2022
Q3 | – | Sell |
-1,483
| Closed | -$14K | – | 2816 |
|
|
2022
Q2 | $14K | Buy |
+1,483
| New | +$14K | ﹤0.01% | 2083 |
|
|
2018
Q2 | – | Sell |
-1,030
| Closed | -$134K | – | 1970 |
|
|
2018
Q1 | $134K | Sell |
1,030
-1,900
| -65% | -$247K | ﹤0.01% | 1616 |
|
|
2017
Q4 | $285K | Buy |
+2,930
| New | +$285K | ﹤0.01% | 1521 |
|